Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of March 28, 2025 • 12:31 PM ET

Date/Time Source News Release
03/28/2025 08:15 AM EDT Business Wire Upcoming Aditxt Weekly Update to Highlight Pearsanta's Acquisition of the Adductomics-Based CaSe Platform and its Potential for Early Cancer Detection
03/24/2025 08:30 AM EDT PR Newswire Evofem Reports Fourth Consecutive Year of Net Sales Growth
03/24/2025 08:15 AM EDT Business Wire Aditxt Subsidiary Pearsanta Completes the Acquisition of Proprietary Adductomics Technology to Develop and Advance the Platform Toward Clinical and Commercial Applications for Monitoring Early Signs of Increased Cancer Risk
03/18/2025 07:22 AM EDT GlobeNewswire Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update
03/17/2025 08:15 AM EDT Business Wire Aditxt Provides Business Status Overview and Announces Launch of Aditxt Weekly Update Starting Friday, March 21, 2025
03/12/2025 04:15 PM EDT Business Wire Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-250 Reverse Stock Split Effective at the Open of Trading on March 17, 2025
03/06/2025 08:15 AM EST Business Wire Aditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany, and Stiff Person Syndrome at the Mayo Clinic in the U.S.
02/21/2025 08:15 AM EST Business Wire Aditxt Subsidiary Pearsanta Engages Dominari Securities for its Initial Public Offering, to Drive U.S. and Global Commercial Launch of Early Cancer Detection and Diagnosis Targeted for H2 2025
02/14/2025 05:06 PM EST GlobeNewswire Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025
02/13/2025 08:15 AM EST Business Wire Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern Time
Page

Additional News

As of March 28, 2025 • 12:31 PM ET

Date/Time Source News Release
03/28/2025 09:35 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Highlights CaSe Platform Acquisition in Weekly Update Focused on Early Cancer Detection
03/24/2025 09:45 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Subsidiary Pearsanta Acquires Patents for DNA Damage Detection in Cancer Prevention
03/18/2025 09:20 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Provides Update on Appili Therapeutics Acquisition and Federal Funding Applications
03/18/2025 08:31 AM EDT 24/7 Market News Appili Therapeutics Seeks $117.5M in Funding and Provides Aditxt Deal Updates
03/17/2025 11:44 AM EDT InvestorBrandNetwork BioMedNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Provides Corporate Update, Announces Weekly Investor Series 
03/17/2025 09:02 AM EDT KlickAnalytics ADTX announced stock split 1-250
03/12/2025 04:20 PM EDT SeekingAlpha Aditxt shares fall on 1-for-250 reverse stock split
03/06/2025 08:50 AM EST InvestorBrandNetwork InvestorNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Advances ADI-100 Autoimmune Therapy Toward Clinical Trials
02/21/2025 09:32 AM EST InvestorBrandNetwork BioMedNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Subsidiary Pearsanta Engages Lead Underwriter for Planned IPO
02/13/2025 11:49 AM EST InvestorBrandNetwork BioMedNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) to Host Fireside Chat on Feb. 21 to Discuss Key Corporate Developments
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.